✦ LIBER ✦

Pharmacologic Risk Mitigation (β-Blockers, Statins, α-2-Agonists)

✍ Scribed by Kalinsky, Bradley; Rice, Elizabeth A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synthesis, Pharmacology, and Biostructur

✍ Ussing, Christine A.; Hansen, Camilla P.; Petersen, Jette G.; Jensen, Anders A.; 📂 Article 📅 2013 🏛 American Chemical Society 🌐 English ⚖ 529 KB

Pharmacological profile of the α4β2 nico

✍ H. Rollema; L.K. Chambers; J.W. Coe; J. Glowa; R.S. Hurst; L.A. Lebel; Y. Lu; R. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 363 KB

Preclinical pharmacology of the α4β2 nAC

✍ Hans Rollema; Mihály Hajós; Patricia A. Seymour; Rouba Kozak; Mark J. Majchrzak; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 562 KB

Chemistry, Pharmacology, and Behavioral

✍ Zhang, Han-Kun; Yu, Li-Fang; Eaton, J. Brek; Whiteaker, Paul; Onajole, Oluseye K 📂 Article 📅 2013 🏛 American Chemical Society 🌐 English ⚖ 461 KB